Martín-Delgado Fernando
Director/Board Member presso PHARMA MAR, S.A.
Profilo
Martín-Delgado Fernando is currently the Director at Pharma Mar SA. Prior to this, he was the Chief Executive Officer & Director at GENOMICA SA (Spain) from 2021 to 2022.
He also held positions as the Marketing Director at Rhône-Poulenc, Inc., Product Manager at GSK Plc, General Manager at Almirall De Mexico, S.A.
De C.V.
from 2013 to 2016, and General Manager at Syneos Health Clinical Spain SLU from 2021 to 2022.
Additionally, he served as the Vice President & General Manager at IQVIA from 2001 to 2012.
Mr. Fernando is a Founding Partner at Mdsan Farmainvest SL.
He obtained his undergraduate degree from Universidad Autónoma de Madrid in 1983.
Posizioni attive di Martín-Delgado Fernando
Società | Posizione | Inizio |
---|---|---|
PHARMA MAR, S.A. | Director/Board Member | 21/12/2022 |
Precedenti posizioni note di Martín-Delgado Fernando
Società | Posizione | Fine |
---|---|---|
GENOMICA SA (Spain)
GENOMICA SA (Spain) Miscellaneous Commercial ServicesCommercial Services GENOMICA SAU provides genetic identification and molecular diagnostic services. Its services include paternity tests, fornsic genetics technological transfers and laboratory genetic identification for criminal investigation. The firm also offers various diagnostic kits and reagents such as CLART PneumoVir, CLINICAL ARRAYS Metabona and CLINICAL ARRAYS-Papillomavirus. It also provides laboratory installation and technical support services and training courses for laboratory, clinical and forensics professionals. The company was founded in 1990 and is headquartered in Madrid, Spain. | Chief Executive Officer | 01/11/2022 |
Syneos Health Clinical Spain SLU | Corporate Officer/Principal | 01/01/2022 |
Almirall De Mexico, S.A. De C.V.
Almirall De Mexico, S.A. De C.V. Pharmaceuticals: MajorHealth Technology Almirall De Mexico, S.A. De C.V. operates as pharmaceutical company, which engages in the research and development of medicines and medical devices for respiratory, autoimmune, dermatological, and gastrointestinal diseases. The company is headquartered in Mexico City, Mexico. | Corporate Officer/Principal | 01/01/2016 |
IQVIA | Corporate Officer/Principal | 01/01/2012 |
Rhône-Poulenc, Inc. | Sales & Marketing | 01/01/1988 |
Formazione di Martín-Delgado Fernando
Universidad Autónoma de Madrid | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
GSK PLC | Health Technology |
PHARMA MAR, S.A. | Health Technology |
Aziende private | 5 |
---|---|
GENOMICA SA (Spain)
GENOMICA SA (Spain) Miscellaneous Commercial ServicesCommercial Services GENOMICA SAU provides genetic identification and molecular diagnostic services. Its services include paternity tests, fornsic genetics technological transfers and laboratory genetic identification for criminal investigation. The firm also offers various diagnostic kits and reagents such as CLART PneumoVir, CLINICAL ARRAYS Metabona and CLINICAL ARRAYS-Papillomavirus. It also provides laboratory installation and technical support services and training courses for laboratory, clinical and forensics professionals. The company was founded in 1990 and is headquartered in Madrid, Spain. | Commercial Services |
Rhône-Poulenc, Inc. | Process Industries |
Almirall De Mexico, S.A. De C.V.
Almirall De Mexico, S.A. De C.V. Pharmaceuticals: MajorHealth Technology Almirall De Mexico, S.A. De C.V. operates as pharmaceutical company, which engages in the research and development of medicines and medical devices for respiratory, autoimmune, dermatological, and gastrointestinal diseases. The company is headquartered in Mexico City, Mexico. | Health Technology |
Syneos Health Clinical Spain SLU | |
IQVIA |
- Borsa valori
- Insiders
- Martín-Delgado Fernando